New Targets for Antivirals: The Ribosomal A-Site and the Factors That Interact with It
- 1 August 2002
- Vol. 300 (1) , 60-70
- https://doi.org/10.1006/viro.2002.1567
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Crystal structures of nucleotide exchange intermediates in the eEF1A-eEF1Balpha complex.Nature Structural & Molecular Biology, 2001
- Structural Basis for Nucleotide Exchange and Competition with tRNA in the Yeast Elongation Factor Complex eEF1A:eEF1BαMolecular Cell, 2000
- Mutations in a GTP-binding Motif of Eukaryotic Elongation Factor 1A Reduce Both Translational Fidelity and the Requirement for Nucleotide ExchangeJournal of Biological Chemistry, 1999
- Mutations in Elongation Factor 1β, a Guanine Nucleotide Exchange Factor, Enhance Translational FidelityMolecular and Cellular Biology, 1999
- Site-directed Mutagenesis of Yeast eEF1AJournal of Biological Chemistry, 1998
- Peptidyl-transferase inhibitors have antiviral properties by altering programmed −1 ribosomal frameshifting efficiencies: Development of model systemsProceedings of the National Academy of Sciences, 1997
- The structure of elongation factor G in complex with GDP: conformational flexibility and nucleotide exchangeStructure, 1996
- Ribosomal frameshifting on viral RNAsJournal of General Virology, 1995
- A -1 ribosomal frameshift in a double-stranded RNA virus of yeast forms a gag-pol fusion protein.Proceedings of the National Academy of Sciences, 1991
- The trichodermin group of antibiotics, inhibitors of peptide bond formation by eukaryotic ribosomesBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1973